Table 4 The selected CTL epitopes of HPV L1 protein based on binding affinity.

From: In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine

Protein Name

Position

Epitope Sequence

No. of Alleles

Top alleles

NetMHCpan Average Rank Scores*

ProPred-I Average Scores**

Syfpeithi Average Scores**

Conservancy (=>75%)

Allergenicity

L1

12–21 (Type 16)

YLPPVPVSKV

17

HLA-A02:01

HLA-A03:01

HLA-B07:02

0.574

97.324

17.285

Type 31: 100%

Type 33: 100%

Type 35: 100%

Type 51: 100%

Type 52: 100%

Type 58: 100%

Type 56: 90%

Non-allergen

12–21 (Type 18)

YLPPPSVARV

17

HLA-A02:01

HLA-A03:01

HLA-A26:01

0.616

96.521

16.818

Type 45: 100%

Type 39: 90%

Type 59: 90%

Type 68: 90%

Non-allergen

114–125 (Type 16)

GVGISGHPLLNK

13

HLA-A03:01

HLA-B58:01

0.911

61.956

13.673

Type 31: 100%

Type 33: 100%

Type 35: 100%

Type 52: 100%

Type 51: 83.33%

Type 58: 83.33%

Non-allergen

104–115 (Type 18)

GVEIGRGQPLGV

12

HLA-B08:01

HLA-B39:01

HLA-B40:01

0.831

64.810

13.678

Type 59: 100%

Type 68: 100%

Type 39: 91.67%

Type 45: 91.67%

Type 51: 91.67%

Type 58: 91.67%

Type 56: 75%

Non-allergen

114–125 (Type 18)

GVGLSGHPFYNK

11

HLA-A01:01

HLA-A03:01

HLA-B58:01

0.840

63.982

14.129

Type 45: 91.67%

Type 59: 91.67%

Type 51: 83.33%

Type 68: 83.33%

Non-allergen

411–421 (Type 16)

GGTLEDTYRFV

14

HLA-A01:01

HLA-A02:01

HLA-A03:01

0.789

68.232

14.750

Type 31: 81.82%

Type 33: 63.64%

Type 35: 81.82%

Non-allergen

414–425 (Type 18)

PTTSLVDTYRFV

14

HLA-A01:01

HLA-A02:01

HLA-A03:01

0.850

75.541

15.868

Type 45: 100%

Type 59: 91.67%

Type 33: 75%

Type 52: 75%

Type 58: 75%

Non-allergen

460–470 (Type 16)

DQFPLGRKFLL

16

HLA-B08:01

HLA-B07:02

HLA-A24:02

HLA-A26:01

HLA-B39:01

0.757

79.497

16.523

Type 31: 100%

Type 33: 100%

Type 35: 100%

Type 39: 100%

Type 52: 100%

Type 58: 100%

Type 59: 100%

Type 68: 100%

Type 51: 90.91%

Type 56: 90.91%

Type 18: 81.82%

Type 45: 81.82%

Non-allergen

461–471 (Type 18)

DQYPLGRKFLV

17

HLA-B08:01

HLA-B07:02

HLA-A24:02

HLA-A26:01

HLA-B39:01

0.723

129.350

16.531

Type 45: 100%

Type 16: 81.82%

Type 31: 81.82%

Type 33: 81.82%

Type 35: 81.82%

Type 39: 81.82%

Type 52: 81.82%

Type 56: 81.82%

Type 58: 81.82%

Type 59: 81.82%

Type 68: 81.82%

Non-allergen

  1. *lower rates show better binding affinity, **Higher rates show better binding affinity.